Clincosm LogoSign in Get a demo

Primary Myelofibrosis

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Berkeley, California
  • +176 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

Completed
  • Primary Myelofibrosis
  • Anemia
  • Phoenix, Arizona
  • +24 more
Aug 17, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +61 more
May 5, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +166 more
Jan 27, 2022

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +121 more
Oct 21, 2021

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +4 more
  • Scottsdale, Arizona
  • +21 more
Jan 18, 2021

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +80 more
Sep 25, 2020

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +113 more
Apr 13, 2020

Primary Myelofibrosis, MPN-associated Myelofibrosis Trial in Worldwide (Pomalidomide 0.5 mg, Placebo, Pomalidomide)

Completed
Has Results
  • Primary Myelofibrosis
  • MPN-associated Myelofibrosis
  • Pomalidomide 0.5 mg
  • +2 more
  • Scottsdale, Arizona
  • +86 more
Jun 24, 2019